Tuesday, 02 January 2024 12:17 GMT

Share Buy-Back Program


(MENAFN- GlobeNewsWire - Nasdaq) COMPANY ANNOUNCEMENT NO 57/2025 - November 17, 2025

On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025.

The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016.

The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The total transaction value of the share buy-backs in the period will not exceed DKK 300m.
The following transactions on Nasdaq Copenhagen A/S have been made under the program:

Number of
Shares
Average purchase price DKK Transaction value, DKK
Accumulated, last announcement 453,500 487.39 221,029,385
November 10, 2025 5,000 499.86 2,499,300
November 11, 2025 4,000 512.46 2,049,840
November 12, 2025 4,000 520.88 2,083,520
November 13, 2025 3,000 541.05 1,623,150
November 14, 2025 3,000 538.79 1,616,370
Total accumulated under the program 472,500 488.68 230,901,565

With the transactions stated above Royal Unibrew owns a total of 1,075,442 shares, corresponding to 2.1% of the share capital. The total amount of shares in the company is 50,200,000, including treasury shares.

For further information please contact:
Flemming Ole Nielsen (Head of Investor Relations)
E-mail:...
Telephone: +45 25 41 68 04

Encl.

Attachments

  • Fond-RU-57-2025-uk-SBB
  • Royal Unibrew SBB AUG-DEC 2025_10NOV-14NOV

MENAFN17112025004107003653ID1110353614



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search